학술논문
Vedolizumab as the First-Line of Biologicals for Pediatric Patients With Ulcerative Colitis
Document Type
Article
Author
Source
In: Clinical Therapeutics . (Clinical Therapeutics, July 2022, 44(7):1028-1032)
Subject
Language
English
ISSN
1879114X
01492918
01492918